Answers are grounded in this paper and cite their sources.
Protocol assesses psychedelic therapy's effects on anxiety and depression in palliative care, suggesting potential benefits.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of psychedelic/entactogen‐assisted therapy compared to placebo or active comparators (e.g. antidepressants) for treatment of anxiety, depression, and existential distress in adult palliative care.
No takes yet. Share an insight, caveat, or question.
Schipper et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: